Anti-cd80 monoclonal antibody Idec 114
We provide customized and high-quality galiximab product for your project.
Galiximab is a chimeric monoclonal antibody directed against CD80. Galiximab binds to CD80 and induces cross-linking of CD80 molecules and cell-death via ADCC. Galiximab has been investigated for the treatment of relapsed Hodgkin lymphoma.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View